4.2 Review

Antagonist molecules in the treatment of angina

Journal

EXPERT OPINION ON PHARMACOTHERAPY
Volume 14, Issue 17, Pages 2323-2342

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1517/14656566.2013.834329

Keywords

angina pectoris; cell therapy; gene therapy; novel drugs; pharmacological management

Funding

  1. Pfizer
  2. Park-Davis
  3. Brigham & Women's Hospital
  4. Fujisawa Healthcare
  5. Gilead Sciences
  6. Baxter
  7. AstraZeneca
  8. Cytori
  9. Amorcyte/Neostem
  10. InfraReDx
  11. NIH/NHLBI
  12. AHA
  13. NHLBI/NCRR CTSA [UL1TR000064]
  14. Sanofi-Aventis

Ask authors/readers for more resources

Introduction: Management of chronic angina has evolved dramatically in the last few decades with several options for pharmacotherapy outlined in various evidence-based guidelines. Areas covered: There is a growing list of drugs that are currently being investigated for treatment of chronic angina. These also include several herbal medications, which are now being scientifically evaluated as potential alternative or even adjunctive therapy for angina. Gene-and cell-based therapies have opened yet another avenue for management of chronic refractory angina in 'no-option' patients who are not candidates for either percutaneous or surgical revascularization and are on optimal medical therapy. An extensive review of literature using PUBMED, Cochrane database, clinical trial databases of the USA and European Union was done and summarized in this review. This review will attempt to discuss the traditional as well as novel therapeutic agents for angina. Expert opinion: Several pharmacological and non-pharmacological therapeutic options are now available for treatment and management of chronic refractory angina. Renewed interest in traditional therapies and cell-and gene-based modalities with targeted drug delivery systems will open the doors for personalized therapy for patients with chronic refractory angina.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Cardiac & Cardiovascular Systems

What Is the Role of Assessing Ischemia to Optimize Therapy and Outcomes for Patients with Stable Angina and Non-obstructed Coronary Arteries?

Colin Berry, Andrew J. Morrow, Mario Marzilli, Carl J. Pepine

Summary: Ischemic heart disease is a leading global health issue, with major subtypes including coronary heart disease and vasomotor disorders. Men are more likely to have coronary heart disease, while women are more likely to have vasomotor disorders. The diagnostic accuracy of tests differs for different subtypes, emphasizing the need for personalized clinical management.

CARDIOVASCULAR DRUGS AND THERAPY (2022)

Editorial Material Cardiac & Cardiovascular Systems

First and recurrent events in the ISCHEMIA trial: two sides of the same coin

Davide Cao, Carl J. Pepine, Roxana Mehran

EUROPEAN HEART JOURNAL (2022)

Article Public, Environmental & Occupational Health

Evaluation of the key prescription sequence symmetry analysis assumption using the calcium channel blocker: Loop diuretic prescribing cascade

Scott M. Vouri, Earl J. Morris, Silken A. Usmani, Rachel Reise, Xinyi Jiang, Carl J. Pepine, Todd M. Manini, Daniel C. Malone, Almut G. Winterstein

Summary: The study evaluated the balance between initiation rates of marker drug before and after initiation of an index drug in the absence of prescribing cascades. The results confirmed the prescription sequence symmetry analysis assumption, as loop diuretic initiation rates before and after DH CCB initiation were similar when not influenced by prescribing cascades.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2022)

Article Cardiac & Cardiovascular Systems

Specialized Proresolving Mediators in Symptomatic Women With Coronary Microvascular Dysfunction (from the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD [WARRIOR] Trial)

Ellen C. Keeley, Han J. Li, Christopher R. Cogle, Eileen M. Handberg, C. Noel Bairey Merz, Carl J. Pepine

Summary: This study found that in female patients with CMD, plasma levels of resolvin D1 and maresin 1 were significantly lower, while levels of docosahexaenoic acid and 18-hydroxyeicosapentaenoic acid were significantly higher. This suggests that insufficient or ineffective production of SPM may play a role in the pathophysiology of CMD.

AMERICAN JOURNAL OF CARDIOLOGY (2022)

Review Cardiac & Cardiovascular Systems

Gut Microbiome and Neuroinflammation in Hypertension

Elaine M. Richards, Jing Li, Bruce R. Stevens, Carl J. Pepine, Mohan K. Raizada

Summary: Hypertension is a global health problem with significant impacts on morbidity, mortality, and healthcare resource utilization. The prevalence of hypertension is increasing, affecting nearly 50% of American adults. Despite the availability of multiple antihypertensive drugs and lifestyle modifications, blood pressure control remains inadequate in about 1 in 5 hypertensive individuals. This review discusses the hypothesis of the gut-brain axis in hypertension, highlighting the involvement of gut physiology, gut microbiota, and neuroinflammation. The dysfunction of this axis contributes to hypertension through inflammatory mediators, metabolites, gut bacteria, and altered afferent information, leading to neuroinflammation and dysregulated autonomic nervous system activity. Understanding these mechanisms could potentially lead to more effective treatments for hypertension.

CIRCULATION RESEARCH (2022)

Editorial Material Cardiac & Cardiovascular Systems

Heart and brain interactions: is small vessel disease a link?

Carl J. Pepine, C. Noel Bairey Merz

EUROPEAN HEART JOURNAL (2023)

Article Cardiac & Cardiovascular Systems

Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida plus Clinical Research Network

Steven M. M. Smith, Almut G. G. Winterstein, Matthew J. J. Gurka, Marta G. G. Walsh, Shailina Keshwani, Anne M. M. Libby, William R. R. Hogan, Carl J. J. Pepine, Rhonda M. M. Cooper-DeHoff

Summary: This study reveals significant variation in initial antihypertensive prescribing among new users, highlighting a gap between current guideline recommendations and real-world implementation in early hypertension care.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Letter Cardiac & Cardiovascular Systems

Long-Term Adverse Outcomes in Black Women With Ischemia and No Obstructive Coronary Artery Disease: A Study of the WISE (Women's Ischemia Syndrome Evaluation) Cohort

Judy M. Luu, Pankaj Malhotra, Galen Cook-Wiens, Carl J. Pepine, Eileen M. Handberg, Steven E. Reis, Nathaniel Reichek, Vera Bittner, Janet Wei, Sheryl F. Kelsey, Reddy Sailaja Marpuri, George Sopko, C. Noel Bairey Merz

CIRCULATION (2023)

Article Public, Environmental & Occupational Health

High-throughput screening for prescribing cascades among real world statin initiators

Scott M. Vouri, Earl J. Morris, Marta Walsh, Jessica Agalliu, Alyssa Dempsey, Leonie Hochleitner, Matthew R. Muschett, Stephan Schmidt, Carl J. Pepine, Steven M. Smith

Summary: This study aimed to comprehensively assess prescribing cascades related to statin medications. The results identified potential prescribing cascades, including laxatives, analgesics, and cephalosporins. These findings are important for reducing the occurrence of prescribing cascades.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2023)

Article Cardiac & Cardiovascular Systems

Host-Microbiota Communication in Spontaneously Hypertensive Rats Generates Unique IgA-Coated Gut Microbes

Jing Li, Elaine M. Richards, Ramakumar Tummala, Carl J. Pepine, Mohan K. Raizada, Tao Yang

Summary: Hypertension is associated with gut dysbiosis and altered intestinal immunity. Using sorting techniques and gene sequencing, we found significant differences in IgA(+) and IgA(-) bacteria between hypertensive and normotensive rats. We also identified several IgA-coated bacteria that were negatively correlated with various pathways involved in immune response and epithelium development.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Cardiac & Cardiovascular Systems

Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline-Based Chemotherapy

David L. DeRemer, Nam K. Nguyen, Avirup Guha, Faraz S. Ahmad, Rhonda M. Cooper-DeHoff, Carl J. Pepine, Michael G. Fradley, Yan Gong

Summary: This study evaluated the differences in cardiac surveillance among different racial and ethnic groups among survivors of cancer after exposure to anthracycline-based treatment. The study found that African American and Hispanic patients had lower participation rates in cardiac surveillance. These results suggest that healthcare providers need to be aware of social inequities and take measures to ensure recommended cardiac surveillance after anthracycline therapy.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Review Cardiac & Cardiovascular Systems

Circulating Biomarkers in Coronary Microvascular Dysfunction

Teja Chakrala, Roshni Prakash, Carlos Valdes, Carl J. J. Pepine, Ellen C. C. Keeley

Summary: Coronary microvascular dysfunction is often unrecognized but has significant clinical implications. Circulating biomarkers can provide valuable information for the diagnosis and management of this condition, reflecting key pathological processes like inflammation, endothelial dysfunction, oxidative stress, coagulation, and others.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Cardiac & Cardiovascular Systems

Longitudinal cardiac remodeling in collegiate American football players as assessed by echocardiography during their collegiate career

Robert F. Hamburger, Yasmeen Taha, Mohammed Ruzieh, James R. Clugston, Eileen M. Handberg, Fred Reifsteck, Matthew W. Martinez, Carl J. Pepine, Katherine M. Edenfield

Summary: This study investigated the effects of intense training on cardiac remodeling in American collegiate football players. The findings showed that training was associated with increases in chamber sizes, left atrial size, and aortic root diameter.

CLINICAL CARDIOLOGY (2023)

Article Pharmacology & Pharmacy

Modifiable statin characteristics associated with potential statin-related prescribing cascades

Grace Hsin-Min Wang, Earl Morris, Scott M. Vouri, Shailina Keshwani, Stephan Schmidt, Carl J. Pepine, Steven M. Smith

Summary: This study aims to identify modifiable statin characteristics associated with lower risk of prescribing cascades. The results show that compared to low-intensity statins, moderate- or high-intensity statins and the choice of individual statin agents are associated with increased risk of prescribing cascades.

PHARMACOTHERAPY (2023)

Article Medicine, General & Internal

Symptom Presentation among Women with Suspected Ischemia and No Obstructive Coronary Artery Disease (INOCA)

Yasmeen K. Taha, Jennifer R. Dungan, Michael T. Weaver, Ke Xu, Eileen M. Handberg, Carl J. Pepine, C. Noel Bairey Merz

Summary: Identifying ischemic heart disease (IHD) in women based on symptoms is challenging, as women are more likely to experience non-cardiac symptoms. More than 50% of women with suspected ischemia have no obstructive coronary disease, leading to impaired outcomes during follow-up. A study aimed to identify symptoms that can predict non-obstructive coronary artery disease (INOCA) in women with clinical evidence of coronary ischemia. The study found that age, left side chest pain, chest discomfort, neck pain, and palpitations had a positive relationship with INOCA, while impending doom and pain in the jaw, left or bilateral arm, and right hand were inversely related to INOCA. The best-fit model accurately predicted INOCA based on age and symptom presentation about 72% of the time.

JOURNAL OF CLINICAL MEDICINE (2023)

No Data Available